Boston Trust Walden Corp Sells 48,731 Shares of Agilent Technologies, Inc. $A

Boston Trust Walden Corp lowered its holdings in Agilent Technologies, Inc. (NYSE:A) by 17.5% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 229,761 shares of the medical research company’s stock after selling 48,731 shares during the quarter. Boston Trust Walden Corp’s holdings in Agilent Technologies were worth $29,490,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors also recently modified their holdings of A. Vanguard Group Inc. raised its position in Agilent Technologies by 1.8% in the 2nd quarter. Vanguard Group Inc. now owns 33,997,845 shares of the medical research company’s stock worth $4,012,086,000 after buying an additional 589,219 shares during the last quarter. Massachusetts Financial Services Co. MA boosted its holdings in shares of Agilent Technologies by 10.7% during the 2nd quarter. Massachusetts Financial Services Co. MA now owns 13,227,387 shares of the medical research company’s stock valued at $1,560,964,000 after acquiring an additional 1,273,994 shares during the last quarter. Geode Capital Management LLC grew its stake in shares of Agilent Technologies by 1.6% in the second quarter. Geode Capital Management LLC now owns 7,319,530 shares of the medical research company’s stock worth $860,137,000 after acquiring an additional 115,183 shares during the period. Generation Investment Management LLP grew its stake in shares of Agilent Technologies by 15.9% in the second quarter. Generation Investment Management LLP now owns 5,775,860 shares of the medical research company’s stock worth $681,609,000 after acquiring an additional 792,304 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in shares of Agilent Technologies by 18.7% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,836,105 shares of the medical research company’s stock valued at $448,748,000 after purchasing an additional 604,124 shares during the last quarter.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on A shares. Robert W. Baird raised their target price on shares of Agilent Technologies from $142.00 to $165.00 and gave the stock an “outperform” rating in a report on Tuesday, November 25th. Wall Street Zen raised Agilent Technologies from a “hold” rating to a “buy” rating in a report on Friday, October 3rd. Morgan Stanley started coverage on Agilent Technologies in a research note on Tuesday, December 2nd. They issued an “overweight” rating on the stock. Wells Fargo & Company upped their price objective on Agilent Technologies from $150.00 to $175.00 and gave the company an “overweight” rating in a research report on Tuesday, November 25th. Finally, TD Cowen increased their target price on Agilent Technologies from $150.00 to $162.00 and gave the company a “buy” rating in a report on Tuesday, October 14th. One equities research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat, Agilent Technologies has an average rating of “Moderate Buy” and an average price target of $161.77.

Agilent Technologies Trading Down 0.4%

NYSE:A opened at $137.86 on Tuesday. Agilent Technologies, Inc. has a one year low of $96.43 and a one year high of $160.27. The business has a fifty day moving average price of $145.20 and a 200-day moving average price of $131.04. The firm has a market capitalization of $39.08 billion, a price-to-earnings ratio of 30.17, a price-to-earnings-growth ratio of 4.02 and a beta of 1.27. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.96 and a quick ratio of 1.52.

Agilent Technologies (NYSE:A) last released its earnings results on Monday, November 24th. The medical research company reported $1.59 earnings per share for the quarter, beating the consensus estimate of $1.58 by $0.01. The company had revenue of $1.86 billion for the quarter, compared to the consensus estimate of $1.83 billion. Agilent Technologies had a return on equity of 25.20% and a net margin of 18.75%.Agilent Technologies’s quarterly revenue was up 9.4% compared to the same quarter last year. During the same period in the previous year, the business earned $1.46 earnings per share. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. Sell-side analysts forecast that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 28th. Shareholders of record on Tuesday, January 6th will be paid a dividend of $0.255 per share. This represents a $1.02 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date is Tuesday, January 6th. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.25. Agilent Technologies’s dividend payout ratio (DPR) is 21.66%.

Insider Activity at Agilent Technologies

In other Agilent Technologies news, VP Rodney Gonsalves sold 3,000 shares of the company’s stock in a transaction that occurred on Wednesday, November 26th. The shares were sold at an average price of $154.99, for a total value of $464,970.00. Following the completion of the transaction, the vice president directly owned 31,846 shares in the company, valued at $4,935,811.54. This represents a 8.61% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Padraig Mcdonnell sold 12,490 shares of the stock in a transaction on Wednesday, November 12th. The stock was sold at an average price of $150.00, for a total transaction of $1,873,500.00. Following the completion of the sale, the chief executive officer directly owned 33,448 shares of the company’s stock, valued at approximately $5,017,200. This trade represents a 27.19% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 16,401 shares of company stock worth $2,468,962 in the last ninety days.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.